Publication | Closed Access
Efficacy of a tetravalent dengue vaccine in healthy children aged 4–16 years: a randomised, placebo-controlled, phase 3 trial
237
Citations
18
References
2020
Year
VaccinationVaccine SafetyPediatricsVaccine TrialVaccine EfficacyMedicineHealthy ChildrenTetravalent Dengue Vaccine
| Year | Citations | |
|---|---|---|
Page 1
Page 1